Feb 22, 2021
Microbion Corporation Receives Additional Funding Support from the Cystic Fibrosis Foundation to Speed Advancement of Inhaled Pravibismane
Oct 20, 2020
Synspira Therapeutics Announces Expanded Agreement with Cystic Fibrosis Foundation to Advance Promising Treatments for Cystic Fibrosis
Jun 15, 2020
Quorum Software Hosts Virtual Customer Conference Benefitting the Cystic Fibrosis Foundation
May 28, 2020
Microbion Awarded up to $17.1 Million from CARB-X and the Cystic Fibrosis Foundation to Develop Inhaled Antimicrobial for Chronic Respiratory Infections in CF
Feb 12, 2020
Synspira Therapeutics and Cystic Fibrosis Foundation Sign Agreement to Develop Broad-spectrum Enzyme Replacement for Malabsorption Syndromes
Jan 28, 2020
Groupware Technology Honored by Cystic Fibrosis Foundation with Corporate Breath Award
Nov 26, 2019
Survey Finds People with Cystic Fibrosis Using a CFTR Modulator Have Positive View of Treatment Plans, HCP Relationships, Future
Oct 24, 2019
AbbVie Announces Collaboration with Cystic Fibrosis Foundation
Apr 10, 2019
Synspira Therapeutics Receives Orphan Designation for SNSP113 for the Treatment of Cystic Fibrosis in the European Union
Dec 20, 2018
Proteostasis Therapeutics Provides Clinical Enrollment Update
Dec 13, 2018
Vast Therapeutics Announces Funding from Cystic Fibrosis Foundation for Further Development of BIOC51
Dec 12, 2018
AR-501 (Cystic Fibrosis) Enrolls First Subject in Phase 1/2a Clinical Trial for Treatment of Chronic Lung Infections in Cystic Fibrosis Patients
Dec 04, 2018
Aridis Expands Research Agreement with the Cystic Fibrosis Foundation and is Awarded FDA Expedited Program Designations
Oct 25, 2018
Laurent Pharmaceuticals Welcomes New Investors and Announces Scientific Breakthrough with LAU-7b in Cystic Fibrosis
Sep 25, 2018
Sound Pharmaceuticals to present initial data on the STOP Ototoxicity Study at Cystic Fibrosis Conference
Aug 10, 2018
Novel Drugs and Smart Devices for Respiratory Disorders, 2018-2030 - Evaluation of Approx. 135 Novel Drug Candidates Across Various Stages of Development
Jul 19, 2018
CARSTAR Hits Historic Moment by Launching its 600th North American Collision Repair Facility
Jun 01, 2018
Proteostasis Announces Presentations at the 41st European Cystic Fibrosis Society Conference
May 04, 2018
CARSTAR Gearing up for Shine Month Fundraising to Fight Cystic Fibrosis
Apr 17, 2018
Proteostasis Receives Endorsement from the Cystic Fibrosis Foundation's Therapeutic Development Network for the Study of the Company's Amplifier, PTI-428, in CF Subjects on Background Symdeko(TM) Therapy